Back
Apellis Pharmaceuticals Stock Price Chart
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
24
APLS
Apellis Pharmaceuticals
Last Price:
$18.20
Seasonality Move:
1.64%
7 Day Trial
ALL ACCESS PASS
$
7
Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.
Apellis Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.9 | Sell |
| 20-day SMA: | 21.28 | Sell |
| 50-day SMA: | 24.51 | Sell |
| 200-day SMA: | 31.05 | Sell |
| 8-day EMA: | 19.13 | Sell |
| 20-day EMA: | 20.87 | Sell |
| 50-day EMA: | 23.83 | Sell |
| 200-day EMA: | 31.7 | Sell |
Apellis Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.85 | Sell |
| Relative Strength Index (14 RSI): | 28.14 | Sell |
| Chaikin Money Flow: | -1052357 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.49 - 24.41) | Sell |
| Bollinger Bands (100): | (23.51 - 32.83) | Sell |
Apellis Pharmaceuticals Technical Analysis
| Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Apellis Pharmaceuticals Stock
Is Apellis Pharmaceuticals Stock a Buy?
-
Apellis Pharmaceuticals share price is 18.20 while APLS 8-day simple moving average is 18.90, which is a Sell signal.
-
The stock price of APLS is 18.20 while Apellis Pharmaceuticals 20-day SMA is 21.28, which makes it a Sell.
-
Apellis Pharmaceuticals 50-day simple moving average is 24.51 while APLS share price is 18.20, making it a Sell technically.
-
APLS stock price is 18.20 and Apellis Pharmaceuticals 200-day simple moving average is 31.05, creating a Sell signal.
APLS Technical Analysis vs Fundamental Analysis
Sell
24
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy or a Sell?
-
Apellis Pharmaceuticals stock is rated a SellThe current Apellis Pharmaceuticals [APLS] share price is $18.20. The Score for APLS is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
Apellis Pharmaceuticals Stock Info
Market Cap:
2.3B
Price in USD:
18.20
Share Volume:
2.5M
Apellis Pharmaceuticals 52-Week Range
52-Week High:
50.98
52-Week Low:
17.49
Sell
24
Apellis Pharmaceuticals (APLS)
is a Sell
Apellis Pharmaceuticals Share Price Forecast
-
What is the Apellis Pharmaceuticals stock price today?The Apellis Pharmaceuticals stock price is 18.20 USD today.
-
Will APLS stock go up or go down?Apellis Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Apellis Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Apellis Pharmaceuticals is overvalued.
Is Apellis Pharmaceuticals Stock a Buy?
-
Apellis Pharmaceuticals share price is 18.20 while APLS 8-day exponential moving average is 19.13, which is a Sell signal.
-
The stock price of APLS is 18.20 while Apellis Pharmaceuticals 20-day EMA is 20.87, which makes it a Sell.
-
Apellis Pharmaceuticals 50-day exponential moving average is 23.83 while APLS share price is 18.20, making it a Sell technically.
-
APLS stock price is 18.20 and Apellis Pharmaceuticals 200-day simple moving average is 31.70, creating a Sell signal.
Fundamental Analysis of Apellis Pharmaceuticals
Is Apellis Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.03 per share, an increase this year of $0.70 per share, and an increase next year of $1.01 per share.
Technical Analysis of Apellis Pharmaceuticals
Should I short Apellis Pharmaceuticals stock?
-
APLS Moving Average Covergence Divergence (MACD) indicator is -1.85, suggesting Apellis Pharmaceuticals is a Sell
-
Apellis Pharmaceuticals Relative Strength Index (RSI) is 28.14, which suggest Apellis Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Apellis Pharmaceuticals is (19.49 - 24.41), which suggest Apellis Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Apellis Pharmaceuticals is (23.51 - 32.83), which suggest Apellis Pharmaceuticals is a Sell
* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.